PerSimiO

Predicting Fracture Risk for Patients with Cancer and Osteoporosis

Health Tech & Life Sciences
Active
Pre-Funding Be'er Sheva, Israel Founded 2015
Website ↗
Last updated 2026-06-18
Total raised
$955K
Last: Grant 2017-08
Stage
Pre-Funding
Founded
2015
Headcount
9
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences

About

PerSimiO offers a superior prediction technology based on proprietary simulation of the response of human bones to load. The technology has been validated by ex-vivo experiments on a large cohort of human femurs, using routine CT scans. PerSimiO's patented technology is a fully automated web-service that may be integrated within a hospital PACS or accessed from a web-browser as a locally hosted web-application.

Although the team has applied the technology primarily to femur-related conditions, it plans to expand the list of Simfini applications to assess bone strength in the humerus, vertebrae, and other bones of the body. The company's products target the diagnosis and treatment of a variety of diseases including osteoporosis, metastatic tumors, and injuries that weaken the bone. The products are designed to optimize treatment and improve outcomes at a reduced cost.

Funding history · 2 rounds · $955K total

2017-08
2015-10

Q&A

What is PerSimiO's primary focus?
PerSimiO specializes in predicting fracture risk for patients with cancer and osteoporosis using proprietary simulation technology that analyzes the response of human bones to load.
When was PerSimiO founded?
PerSimiO was founded in January 2015.
What is PerSimiO's total funding to date?
PerSimiO has raised a total of $955,000 through grant funding.
When was PerSimiO's last funding round and who participated?
PerSimiO's last funding round was a Grant in August 2017, with participation from the Israel Innovation Authority.
Who are the co-founders of PerSimiO?
The co-founders of PerSimiO are Prof. Zohar Yosibash (Co-founder & CEO), Dr. Nir Trabelsi, and Prof. MD Charles Milgrom. Eitan Segall was also a co-founder but is no longer with the company.
What is the primary sector of PerSimiO?
PerSimiO's primary sector is Health Tech & Life Sciences.
Does PerSimiO hold any patents?
Yes, PerSimiO holds one patent for its technology.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

orthopedicssimulationdigital-healthcaresaasbonesoftware-applicationsdata-analyticshealthcare-providersdoctorsmachine-learninghospitalspredictive-analyticsartificial-intelligencediabetesimagingdecision-supporttreatmentsrisk-assesmentsct-scan
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)